SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001564590-21-019636
Filing Date
2021-04-20
Accepted
2021-04-20 16:16:01
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFA14A srpt-defa14a_20210603.htm DEFA14A 32007
2 GRAPHIC gqjcopprg2b1000002.jpg GRAPHIC 116420
3 GRAPHIC gqjcopprg2b1000001.jpg GRAPHIC 118856
  Complete submission text file 0001564590-21-019636.txt   357507
Mailing Address 215 FIRST STREET SUITE 415 CAMBRIDGE MA 02142
Business Address 215 FIRST STREET SUITE 415 CAMBRIDGE MA 02142 617-274-4000
Sarepta Therapeutics, Inc. (Filer) CIK: 0000873303 (see all company filings)

IRS No.: 930797222 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-14895 | Film No.: 21838025
SIC: 2834 Pharmaceutical Preparations